Mesanenin Nöroendokrin Tümörleri
Özet
Referanslar
Moch H, Humphrey PA, Ulbright TM, Reuter VE. WHO Classification of Tumours of the Urinary System and Male Genital Organ. Lyon: International Agency for Research on Cancer (IARC) Press, 2016.
Cheng L, Pan CX, Yang XJ, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer. 2004;101:957–962.
Blomjous CE, Vos W, De Voogt HJ, Van der Valk P, Meijer CJ. Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases. Cancer 1989;64:1347–57.
Wang HL, Lu DW. Detection of human papillomavirus DNA and expression of p16, Rb, and p53 proteins in small cell carcinomas of the uterine cervix. Am J Surg Pathol. 2004;28:901–908.
Patel SG, Stimson CJ, Zaid HB, Resnick MJ, Cookson MS, Barocas DA, et al. Locoregional small cell carcinoma of the bladder: clinical characteristics and treatment patterns. J Urol 2014;191:329–34.
Zheng X, Liu D, Fallon JT, Zhong M. Distinct genetic alterations in small cell carcinoma from different anatomic sites. Exp Hematol Oncol 2015;4:2.
Choong NW, Quevedo JF, Kaur JS. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Cancer. 2005;103:1172–1178.
Cheng L, Jones TD, McCarthy RP, Eble JN, Wang M, MacLennan GT, et al. Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am J Pathol 2005;166:1533–9.
Blomjous CE, Vos W, De Voogt HJ, et al. Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases. Cancer. 1989;64:1347–1357.
Terracciano L, Richter J, Tornillo L, et al. Chromosomal imbalances in small cell carcinomas of the urinary bladder. J Pathol. 1999;189:230–235.
Kouba E, Cheng L. Neuroendocrine Tumors of the Urinary Bladder According to the 2016 World Health Organization Classification: Molecular and Clinical Characteristics Endocr Pathol. 2016; 27: 188-199.
Zheng X, Zhuge J, Bezerra SM, et al. High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins. J Hematol Oncol. 2014;7:47.
Pan CX, Yang XJ, Lopez-Beltran A, et al. c-kit Expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications. Mod Pathol. 2005;18:320–323.
Wang X, MacLennan GT, Lopez-Beltran A, Cheng L. Small cell carcinoma of the urinary bladder—histogenesis, genetics, diagnosis, biomarkers, treatment, and prognosis. Appl Immunohistochem Mol Morphol 2007;15:8–18.
Cheng L, Eble JN. Molecular Surgical Pathology. Springer, New York, NY, 2013.
Cheng L, MacLennan GT, Bostwick DG. Urologic Surgical Pathology, Fourth Edıtıon. Philadelphia. Press 2020
Zhou H, Lıu L, Yu G, Qu G, Gong P, Yu X and Yang P. Analysis of Clinicopathological Features and Prognostic Factors in 39 Cases of Bladder Neuroendocrine Carcinoma. Antıcancer Research. 2017; 37: 4529-4537.
Wang X, Jones TD, Maclennan GT, et al. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications. Anticancer Res. 2005;25:2001–2004.
Jones TD, Kernek KM, Yang XJ, et al. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Hum Pathol. 2005;36:718–723.
Iczkowski KA, Shanks JH, Allsbrook WC, et al. Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression. Histopathology. 1999;35:150–156.
Wang G, Xiao L, Zhang M, Kamat AM, Siefker-Radtke A, Dinney CP, Czerniak B and Guo CC. Small Cell Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 81 Cases. Hum Pathol. 2018;79:57-65.
Williamson SR, Zhang S, Yao JL, Huang J, Lopez-Beltran A, Shen S, et al. ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin. Mod Pathol 2011;24:1120–7.
Abenoza P, Manivel C, Sibley RK. Adenocarcinoma with neuroendocrine differentiation of the urinary bladder. Clinicopathologic, immunohistochemical, and ultrastructural study. Arch Pathol Lab Med 1986;110:1062–6.
Lee KH, Ryu SB, Lee MC, et al. Primary large cell neuroendocrine carcinoma of the urinary bladder. Pathol Int. 2006;56:688–693.
Hailemariam S, Gaspert A, Komminoth P, Tamboli P, Amin M. Primary, pure, large-cell neuroendocrine carcinoma of the urinary bladder. Mod Pathol 1998;11:1016–20.
Colarossi C, Pino P, Giuffrida D, Aiello E, Costanzo R, Martinetti D, et al. Large cell neuroendocrine carcinoma (LCNEC) of the urinary bladder: a case report. Diagn Pathol 2013;8:19.
Vollbrecht C, Werner R, Walter RF, Christoph DC, Heukamp LC, Peifer M, et al. Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group. Br J Cancer 2015;113:1704–11.
Serrano FA, Sanchez-Mora N, Arranz JA, Hernandez C and Alvarez-Fernandez E. Large Cell and Small Cell Neuroendocrine Bladder Carcinoma Immunohistochemical and Outcome Study in a Single Institution. Am J Clin Pathol 2007; 128:733-739.
Park S, Reuter VE, Hansel DE. Non-urothelial carcinomas of the bladder. Histopathology 2019,74;97-111.
Bertaccini A, Marchiori D, Cricca A, Garofalo M, Giovannini C, Manferrari F, et al. Neuroendocrine carcinoma of the urinary bladder: case report and review of the literature. Anticancer Res 2008;28:1369–72.
Lee KH, Ryu SB, Lee MC, Park CS, Juhng SW, Choi C. Primary large cell neuroendocrine carcinoma of the urinary bladder. Pathol Int 2006;56:688–93.
Gupta S, Thompson RH, Boorjian SA, Thapa P, Hernandez LP, Jimenez RE, et al. High grade neuroendocrine carcinoma of the urinary bladder treated by radical cystectomy: a series of small cell, mixed neuroendocrine and large cell neuroendocrine carcinoma. Pathology 2015;47:533–42.
Martin IJ, Vilar DG, Aguado JM, Perello CG, Aliaga MR, Argente VG, et al. Large cell neuroendocrine carcinoma of the urinary bladder. Bibliographic review. Arch Esp Urol 2011;64:105–13.
Colby TV. Carcinoid tumor of the bladder. A case report. Arch Pathol Lab Med 1980;104:199–200
Mondal K and Mandal R. A Cacinoid Tumor in the Urinary Bladder with Uncommon Clinicopathological Presentation. Case Report Iran J Pathol. 2017;12:277-280
Mascolo M, Altieri V, Mignogna C, Napodano G, De Rosa G, Insabato L. Calcitonin-producing well-differentiated neuroendocrine carcinoma (carcinoid tumor) of the urinary bladder: case report. BMC Cancer 2005;5:88.
Chen YB, Epstein JI. Primary carcinoid tumors of the urinary bladder and prostatic urethra: a clinicopathologic study of 6 cases. Am J Surg Pathol 2011;35:442–6.
Sugihara A, Kajio K, Yoshimoto T, Tsujimura T, Iwasaki T, Yamada N, et al. Primary carcinoid tumor of the urinary bladder. Int Urol Nephrol 2002;33:53–7.
Martignoni G, Eble JN. Carcinoid tumors of the urinary bladder: immunohistochemical study of two cases and review of the literatüre. Arch Pathol Lab Med 2003;127:e22-e24.
Walker BF, Someren A, Kennedy JC, Nicholas EM. Primary carcinoid tumor of the urinary bladder. Arch Pathol Lab Med 1992;116:1217–20.
Zozumi M, Nakai M, Matsuda I, Hao H, Ueda Y, Nojima M, et al. Primary carcinoid tumor of the urinary bladder with prominent subnuclear eosinophilic granules. Pathol Res Pract 2012;208:109–12.
Dahm P,Gshwend JE:Malignant non-urothelial neoplasms of the urinary bladder: a review. European Urology 2003,44:672-81.
Beilan J, Lawton A, Hajdenberg J, Rosser JC. Locally advanced paraganlioma of the urinary bladder: a case report. BMC Research Notes 2013, 6:156
Safhat AS, Bissada NK. Pheochrochromocytoma of the urinary bladder(J). Can J Urol, 2007,14(6):3757-3760.
Beilan JA, Lawton A, Hajdenberg J, Rosser CJ. Pheochromocytoma of the urinary bladder: a systematic review of the contemporary literature. BMC Urol 2013;13:22.
Lloyd RV, Osamura RY, Kloppel G, Rosai J eds. World Health Organization classification of tumours. Pathology and genetics oftumours of endocrine organs. Lyon: IARC Press, 2017.
Kloeppel G, Lloyd R, Osamura R, Roasi J eds. Pathology and genetics of endocrine organs, 4th edn. Lyon: IARC Press, 2017; 179–195
Gill AJ, Chou A, Vilain R et al. Immunohistochemistry forSDHB divides gastrointestinal stromal tumors (GISTs) into twodistinct types. Am. J. Surg. Pathol. 2010; 34; 636–644
Gill AJ. Succinate dehydrogenase (SDH) and mitochondrial dri-ven neoplasia. Pathology 2012; 44; 285–292.
Nederveen FH, Gaal J, Favier J et al. An immunohisto-chemical procedure to detect patients with paraganglioma andphaeochromocytoma with germline SDHB. SDHC or SDHDgene mutations: a retrospective and prospective analysis. LancetOncol. 2009; 8; 764–771.
Gill AJ, Benn DE, Chou A et al. Immunohistochemistry forSDHB triages genetic testing of SDHB, SDHC and SDHD inparaganglioma–phaeochromocytoma syndromes. Hum. Pathol.2010; 41; 805–814
Honma K. Paraganglia of the urinary bladder. An autopsy study. Zentralbl Pathol 1994;139:465–9.
Lu H, Male M, Jiang K, Ye Z, Song D and Xia D. Clinical significance of functional and anatomical classifications in paraganglioma of the urinary bladder. Urologic Oncology:Seminars and Original Investigations 2019;37: e9-e17.
Cheng L, Leibovich BC, Cheville JC, Ramnani DM, Sebo TJ, Neumann RM, et al. Paraganglioma of the urinary bladder: can biologic potential be predicted? Cancer 2000;88:844–52.
Zhou M, Epstein JI, Young RH. Paraganglioma of the urinary bladder: a lesion that may be misdiagnosed as urothelial carcinoma in transurethral resection specimens. Am J Surg Pathol 2004;28:94–100.
Zhang B, Fu Z, Liu L, Qiao B and Liu C. Non-functional paraganglioma of urinary bladder managed by transurethral resection. Int Braz J Urol. 2019;45:910-5.
So JS, Epstein JI. GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma. Mod Pathol 2013;26:1365–70.
Ranaweera M, Chung E. Bladder paraganglioma: A report of case series and critical review of current literature. World J Clin Cases 2014;2:591–5.